IAEA Training Material on Radiation Protection in Radiotherapy Radiation Protection in Radiotherapy Part 1 Aim and Role of Radiotherapy Introductory Lecture Radiotherapy One of the main treatment modalities for cancer (often in Siemens Oncology combination with chemotherapy and surgery) It is generally assumed that 50 to 60% of cancer patients will benefit from radiotherapy Minor role in other diseases Radiation Protection in Radiotherapy Part 1: Introductory lecture 2 Objectives of the Module To become familiar with the principles of radiotherapy the role of radiotherapy in cancer management the cost effectiveness of radiotherapy To appreciate the importance of radiation dose in radiotherapy Radiation Protection in Radiotherapy Part 1: Introductory lecture 3 Contents of the Lecture 1.Cancer management and radiotherapy 2.Approaches for dose delivery External beam radiotherapy Brachytherapy 3.Features of a radiotherapy department 4.Self test at the end of the lecture ”Quick test” Radiation Protection in Radiotherapy Part 1: Introductory lecture 4 Cancer incidence (WHO) Radiation Protection in Radiotherapy Part 1: Introductory lecture 5 Major indications for radiotherapy Head and neck cancers Gynaecological cancers (e.g. Cervix) Prostate cancer Other pelvic malignancies (rectum, bladder) Adjuvant breast treatment Brain cancers Palliation Radiation Protection in Radiotherapy Part 1: Introductory lecture 6 Approaches Palliative radiotherapy to reduce pain and address acute symptoms – e.g. bone metastasis, spinal cord compression, ... Radical radiotherapy as primary modality for cure – e.g. head and neck Adjuvant treatment in conjunction with surgery – e.g. breast cancer Radiation Protection in Radiotherapy Part 1: Introductory lecture 7 Patient Aim Critical organs To kill ALL viable cancer cells To deliver as much dose as possible to the target while minimising the dose to surrounding healthy tissues Radiation Protection in Radiotherapy Beam directions target Part 1: Introductory lecture 8 Prognostic Factors Cancer type and stage Patient performance Radiation dose ... survival Bad prognosis Radiation Protection in Radiotherapy Part 1: Introductory lecture Good prognosis time 9 Prognostic Factors Cancer type and stage Patient performance Radiation dose ... Accurate dose delivery matters! Radiation Protection in Radiotherapy Part 1: Introductory lecture 10 Dose response 100% response means the tumour is cured with certainty (TCP) or unacceptable normal tissue damage (e.g. paralysis) is inevitable Radiation Protection in Radiotherapy Part 1: Introductory lecture 11 Dose response Therapeutic window: Maximum probability of Complication Free Tumour Control Radiation Protection in Radiotherapy Part 1: Introductory lecture 12 Dose should be accurate To target: 5% too low - may result in clinically detectable reduction in tumour control (e.g. Head and neck cancer: 15%) To normal tissues: 5% too high - may lead to significant increase in normal tissue complication probability = morbidity = unacceptable side effects Radiation Protection in Radiotherapy Part 1: Introductory lecture 13 “Deviations from Prescribed Dose” May involve severe or even fatal consequences. IAEA Basic Safety Standards (SS 115): ”…require prompt investigation by licensees in the event of an accidental medical exposure…” Radiation Protection in Radiotherapy Part 1: Introductory lecture 14 Options for dose delivery External beam radiotherapy = dose is delivered from outside the patient using X Rays or gamma rays or high energy electrons (refer to part 5 of the course) Brachytherapy = dose delivered from radioactive sources implanted in the patient close to the target (brachys = Greek for short distance; refer to part 6 of the course) Radiation Protection in Radiotherapy Part 1: Introductory lecture 15 External beam radiotherapy Radiation Protection in Radiotherapy Part 1: Introductory lecture 16 External Beam Radiotherapy Typically fractionated - e.g. 30 daily fractions of 2Gy up to a total dose of 60Gy Superficial/orthovoltage photons (50 to 400kVp) for skin or superficial lesions Megavoltage photons (60-Co or linear accelerators = linacs) for deeper lying tumours. Megavoltage electrons from linacs for more superficial lesions Radiation Protection in Radiotherapy Part 1: Introductory lecture 17 Superficial/orthovoltage unit Radiation Protection in Radiotherapy Part 1: Introductory lecture 18 Modern Cobalt 60 unit Radiation Protection in Radiotherapy Part 1: Introductory lecture 19 Linear accelerator with electron cone Electron applicator Radiation Protection in Radiotherapy Part 1: Introductory lecture 20 Brachytherapy Interstitial implant for breast radiotherapy Radiation Protection in Radiotherapy Part 1: Introductory lecture Intracavitary gynecological implant 21 Brachytherapy Implant of radioactive materials (e.g. 137-Cs, 192-Ir) close to the target area Intracavitary, interstitial and mould surface applications Low dose rate, LDR, (60Gy in about 5 days) and high dose rate, HDR, (several fractions of several Gy in few minutes each) applications Radiation Protection in Radiotherapy Part 1: Introductory lecture 22 Example for HDR Brachytherapy Radiation Protection in Radiotherapy Part 1: Introductory lecture 23 A radiotherapy department is part of a health system Radiotherapy Department Oncology National Cancer System Host hospital Radiation Protection in Radiotherapy Part 1: Introductory lecture 24 Patient Flow in Radiotherapy …not necessarily a straightforward process Radiation Protection in Radiotherapy Part 1: Introductory lecture 25 Patient flow in radiotherapy Depends on: disease site and stage departmental protocols treating clinician resources available Radiation Protection in Radiotherapy Part 1: Introductory lecture 26 Components of a Radiotherapy Department Diagnostic facilities (CT, MRI, …) Simulator (refer to part 5 of the course) Mouldroom Treatment planning External beam treatment units (parts 5 and 10) Brachytherapy equipment (part 6) Clinic rooms, beds, ... Radiation Protection in Radiotherapy Part 1: Introductory lecture 27 Layout of a Department Radiation Protection in Radiotherapy Part 1: Introductory lecture 28 Layout of a Department Physics & workshops Planning Clinics Offices Radiation Protection in Radiotherapy Simulator Two linac bunkers Patient waiting Part 1: Introductory lecture 29 Professionals in radiotherapy Radiation oncologists Other clinicians Medical radiation physicists Radiation therapists Nursing staff Radiation safety officer Information technology officer Administrative staff Radiation Protection in Radiotherapy Part 1: Introductory lecture 30 Features of Radiotherapy High and potentially lethal absorbed dose is required to cure cancer High technology environment Individualized treatment approach Complex treatment set-up Radiation Protection in Radiotherapy Part 1: Introductory lecture 31 Features of Radiotherapy High and potentially lethal absorbed dose is required to cure cancer High technology environment Individualized treatment approach Complex treatment set-up Quality assurance, treatment verification and radiation protection essential Radiation Protection in Radiotherapy Part 1: Introductory lecture 32 Summary Radiotherapy is an important cancer treatment modality Accuracy of dose delivery is essential for good outcomes The complex and high tech environment requires attention to quality assurance and radiation protection Radiation Protection in Radiotherapy Part 1: Introductory lecture 33 Where to Learn More Other parts of the course, handouts References: Radiotherapy physics textbooks (as per reference list) IUCC Cancer Statistics Radiotherapy textbooks (e.g. Perez and Brady 1998) Site visit of a radiotherapy department (day xxx of the course) Radiation Protection in Radiotherapy Part 1: Introductory lecture 34 Any questions? Radiation Protection in Radiotherapy Part 1: Introductory lecture 35 Question: What is the main cancer treated with radiotherapy in your country and what would be a typical treatment approach? (Number of fractions? Total dose?) Radiation Protection in Radiotherapy Part 1: Introductory lecture 36